In a report released today, William Bonello from Craig-Hallum maintained a Buy rating on GeneDx Holdings (WGS – Research Report). The company’s ...

GeneDx Holdings Corp (NASDAQ:WGS) is set to release its Q4 2024 earnings on Feb 18, 2025. The consensus estimate for Q4 2024 revenue is $82.23 million, and the earnings are expected to come in at -$0.

GeneDx Holdings Corp. (WGS) came out with quarterly earnings of $0.70 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to loss of $0.59 per share a year ago. These ...

The World Government Summit (WGS) kicked off in Dubai on Sunday, February 11th, and will last until the 14th. The guests will ...

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GeneDx Holdings Corp.

The European Commission has adopted legislation requiring EU countries to do Whole Genome Sequencing (WGS) during foodborne ...

The World Governments Summit (WGS) 2025 co-hosted the "TIME100 AI Impact Awards" in partnership with TIME at the Museum of ...

Vietnamese Deputy Prime Minister Bui Thanh Son delivered speeches at two forums themed “Emerging Economies” and “Sustainable ...

PwC Middle East unveiled four strategic papers at the World Governments Summit (WGS) 2025, alongside its second edition of ...

The Abu Dhabi Fund for Development (ADFD) participated in the World Governments Summit 2025, held in Dubai under the theme ...

Below is a chart showing TKO's trailing twelve month trading history, with the $135 strike highlighted in orange: GeneDx Holdings Corp (Symbol: WGS) options are showing a volume of 11,706 ...